"Astatine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Astatine. A radioactive halogen with the atomic symbol At, and atomic number 85. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism because it emits ALPHA PARTICLES.
Descriptor ID |
D001246
|
MeSH Number(s) |
D01.268.271.110 D01.268.380.075 D01.496.749.305.110
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Astatine".
Below are MeSH descriptors whose meaning is more specific than "Astatine".
This graph shows the total number of publications written about "Astatine" by people in this website by year, and whether "Astatine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Astatine" by people in Profiles.
-
a-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10. Cancer Sci. 2018 Jul; 109(7):2302-2309.
-
Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer. Anticancer Res. 2001 Jan-Feb; 21(1A):409-12.
-
The curative and palliative potential of the monoclonal antibody MOv18 labelled with 211At in nude mice with intraperitoneally growing ovarian cancer xenografts--a long-term study. Acta Oncol. 2000; 39(6):741-5.
-
Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18. Anticancer Res. 2000 Jan-Feb; 20(1A):459-62.
-
Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1539-48.
-
Preparation of a biologically stable and immunogenically competent astatinated protein. Int J Nucl Med Biol. 1977 Dec; 4(3-4):219-24.